Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LMAT |
---|---|---|
09:32 ET | 652 | 106.32 |
09:46 ET | 200 | 107.745 |
09:48 ET | 900 | 107.8 |
09:51 ET | 1052 | 107.6689 |
09:53 ET | 100 | 107.575 |
10:06 ET | 500 | 107.91 |
10:08 ET | 200 | 107.605 |
10:09 ET | 139 | 107.361323 |
10:11 ET | 100 | 107.22 |
10:29 ET | 688 | 106.76 |
10:31 ET | 200 | 106.785 |
10:33 ET | 100 | 106.81 |
10:36 ET | 100 | 106.595 |
10:38 ET | 400 | 106.57 |
10:44 ET | 100 | 106.715 |
10:51 ET | 100 | 107.1 |
10:54 ET | 200 | 106.595 |
11:00 ET | 100 | 106.985 |
11:02 ET | 100 | 106.885 |
11:05 ET | 400 | 106.53 |
11:09 ET | 200 | 106.44 |
11:18 ET | 100 | 106.05 |
11:25 ET | 100 | 106.28 |
11:36 ET | 100 | 106.275 |
11:38 ET | 100 | 106.315 |
11:41 ET | 386 | 106.65 |
11:45 ET | 1595 | 106.42 |
11:54 ET | 397 | 106.61 |
12:01 ET | 855 | 106.59 |
12:10 ET | 404 | 106.52 |
12:14 ET | 200 | 106.725 |
12:15 ET | 200 | 106.65 |
12:24 ET | 200 | 106.57 |
12:33 ET | 1000 | 106.2121 |
12:44 ET | 200 | 106.285 |
12:46 ET | 213 | 106.47 |
12:50 ET | 100 | 106.615 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
LeMaitre Vascular Inc | 2.4B | 58.5x | +3.81% |
Transmedics Group Inc | 2.7B | 81.3x | --- |
Cytek Biosciences Inc | 832.1M | -84.9x | --- |
iRhythm Technologies Inc | 2.3B | -15.2x | --- |
Pacific Biosciences of California Inc | 482.4M | -1.3x | --- |
AxoGen Inc | 576.5M | -40.1x | --- |
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4B |
---|---|
Revenue (TTM) | $213.0M |
Shares Outstanding | 22.5M |
Dividend Yield | 0.60% |
Annual Dividend Rate | 0.6400 USD |
Ex-Dividend Date | 11-21-24 |
Pay Date | 12-05-24 |
Beta | 0.91 |
EPS | $1.82 |
Book Value | $13.34 |
P/E Ratio | 58.5x |
Price/Sales (TTM) | 11.2 |
Price/Cash Flow (TTM) | 46.7x |
Operating Margin | 23.29% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.